True North Advisors’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.25M | Buy |
4,847
+3,642
| +302% | +$940K | 0.24% | 79 |
|
2025
Q1 | $270K | Buy |
1,205
+80
| +7% | +$17.9K | 0.05% | 206 |
|
2024
Q4 | $257K | Buy |
+1,125
| New | +$257K | 0.06% | 161 |
|
2022
Q1 | – | Sell |
-32,100
| Closed | -$8.36M | – | 231 |
|
2021
Q4 | $8.36M | Hold |
32,100
| – | – | 1.41% | 12 |
|
2021
Q3 | $8.46M | Hold |
32,100
| – | – | 1.67% | 11 |
|
2021
Q2 | $7.91M | Hold |
32,100
| – | – | 1.65% | 11 |
|
2021
Q1 | $6.23M | Hold |
32,100
| – | – | 1.48% | 13 |
|
2020
Q4 | $6.82M | Hold |
32,100
| – | – | 1.75% | 11 |
|
2020
Q3 | $5.5M | Sell |
32,100
-60,000
| -65% | -$10.3M | 1.61% | 12 |
|
2020
Q2 | $17.7M | Hold |
92,100
| – | – | 4.25% | 4 |
|
2020
Q1 | $13.6M | Hold |
92,100
| – | – | 4.63% | 5 |
|
2019
Q4 | $14.3M | Buy |
+92,100
| New | +$14.3M | 4.02% | 8 |
|